# VACURE Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vacure-biotechnology-co

- Industry: Medical Devices & Equipment
- Headquarters: Chengdu, China
- Website: www.v-acure.com
- Latest round: Series A (Dec 22, 2021)
- Investors on record: 3

## About

Based in Chengdu, China, and established in 2017, VACURE Biotechnology Co.,Ltd. is a healthcare equipment company that focuses on R&D, production, and sales of point-of-care testing (POCT) products. The company established the R&D center, and production base. In 2019, the company established a subsidiary in Sichuan, mainly responsible for the industrialized operation of microfluidic chips. As of 2022, it has 148 employees. 

The company self-developed products that can be diagnostic equipment, pharmaceutical raw materials, and original equipment manufacturer (OEM) equipment. The diagnostic equipment includes DISKFLU microfluidic immune joint inspection platform, LYOFIA microfluidic time-resolved immunofluorescence platform, SARS-CoV-2 antigen detection kit instruction, and MAGFLU flow capture microfluidic platform. The pharmaceutical raw materials include monoclonal antibodies and Nano-material spray freeze-drying reagent balls. Those products can be used for accurate quantitative detection of infectious diseases and to test the incidence of cardiovascular diseases.

The company plans to expand its market share in China and develop new products for detecting common chronic diseases in families.

## Funding rounds

- Series A, Dec 22, 2021 — Wonder Land Capital, Zhengzhou Guotou Asset Management Co., Ltd., Jinggang Capital
- Angel, Feb 11, 2019 — Wonder Land Capital

## Investors

- Wonder Land Capital (https://capitalatlas.ai/funds/wonder-land-capital) — Angel, Series A
- Zhengzhou Guotou Asset Management Co., Ltd. — Series A
- Jinggang Capital (https://capitalatlas.ai/funds/jinggang-capital) — Series A